Special Conditions Require Attention- Those with specific conditions such as eye problems, Lebers disease, kidney or liver disease, iron or folic acid deficiency, infections, or undergoing bone marrow-affecting treatments should seek professional advice
Weight Reduction with Tirzepatide vs other anti-diabetic medications (as presented in EASD 2023) One may wonder how a dual GIP/GLP1 receptor agonist works when one increases glucagon and another decreases glucagon, which may seem contradictory
Lieberman, M., and A
More people hit bigger weight-loss milestones A larger share of tirzepatide users reach 10%, 15%, and 20%+ total weight loss than semaglutide users at comparable time points, though plenty of people reach those same milestones on semaglutide too individual response varies a lot
Sementino, E., Hassan, D., Bellacosa, A